Heron Therapeutics (HRTX) Stock Chart & Stock Price History $2.00 -0.02 (-0.99%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$2.02 +0.02 (+0.75%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Heron Therapeutics Stock Price Performance The Heron Therapeutics (HRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 39.94%, with a year-to-date return of 30.72%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Heron Therapeutics traded at $2.00 with a market cap of $305.13 million and volume of 861,292 shares. Five years ago, the stock traded at $17.77, representing a 88.75% decrease over that period. At the time, it had a market cap of $1.62 billion and a volume of 1.41 million shares. Receive HRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.26%1 Month Performance0.00%3 Month Performance+8.70%Year-To-Date Performance+30.72%1 Year Performance-39.94%5 Year Performance-88.75% HRTX Stock Chart for Friday, July, 18, 2025 HRTX Chart by TradingView Heron Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$2.02$2.00-0.99%$2.05$2.00861,292 shs$305.13 million07/16/2025$2.04$2.02-0.98%$2.09$1.991.05 million shs$308.17 million07/15/2025$2.12$2.04-3.77%$2.14$2.03859,784 shs$311.23 million07/14/2025$2.18$2.12-2.75%$2.19$2.10871,971 shs$323.44 million07/11/2025$2.22$2.18-1.80%$2.25$2.17865,220 shs$332.59 million07/10/2025$2.23$2.22-0.45%$2.25$2.20827,084 shs$338.68 million07/09/2025$2.20$2.23+1.36%$2.28$2.201.08 million shs$340.21 million07/08/2025$2.15$2.20+2.33%$2.23$2.141.05 million shs$335.64 million07/07/2025$2.17$2.15-0.69%$2.23$2.131.46 million shs$328.00 million07/04/2025$2.17$2.17$2.22$2.13823,589 shs$330.30 million Get the Latest News and Ratings for HRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$2.15$2.17+0.70%$2.22$2.13823,589 shs$330.29 million07/02/2025$2.17$2.15-0.92%$2.30$2.112.49 million shs$328.00 million07/01/2025$2.07$2.17+4.83%$2.23$2.042.29 million shs$331.06 million06/30/2025$2.14$2.07-3.27%$2.22$2.061.46 million shs$315.80 million06/27/2025$2.16$2.14-0.93%$2.19$2.095.48 million shs$326.48 million06/26/2025$2.15$2.16+0.47%$2.19$2.12860,196 shs$329.53 million06/25/2025$2.15$2.15$2.23$2.101.74 million shs$328.01 million06/24/2025$2.11$2.15+1.90%$2.20$2.071.14 million shs$328.00 million06/23/2025$2.00$2.11+5.50%$2.20$1.972.12 million shs$321.90 million06/20/2025$2.00$2.00$2.04$1.931.10 million shs$305.13 million06/19/2025$2.00$2.00$2.07$1.931.10 million shs$305.12 million06/18/2025$1.95$2.00+2.56%$2.07$1.931.10 million shs$305.12 million06/17/2025$2.03$1.95-3.94%$2.01$1.933.22 million shs$297.50 million Related Companies Phibro Animal Health Stock Chart AbCellera Biologics Stock Chart Cogent Biosciences Stock Chart Pharvaris Stock Chart Intellia Therapeutics Stock Chart CureVac Stock Chart Aurinia Pharmaceuticals Stock Chart WAVE Life Sciences Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Enliven Therapeutics Stock Chart Receive HRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HRTX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
